CClinicalTrials.gg
CompletedNCT01206842Updated May 22, 2018

Social Cognition Training in Schizophrenia

An interventional study of Training in Affect Recognition in Schizophrenia and Social Cognition, sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2018-05-22.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

People with schizophrenia show deficits in social cognition, the ability to process information about other people such as identifying their emotional expressions. Social cognition is associated with everyday life functioning and could therefore be an important treatment target. Several social cognitive training programs have been developed during the last years. Results indicate that social cognitive performance can be ameliorated through commonly used intervention techniques. However, it is less clear whether this improvement generalizes to everyday life. The purpose of this study is to investigate if a social cognitive training program (Training in Affect Recognition) improves performance on social cognitive and neuropsychological tests and leads to improved everyday life functioning in persons with schizophrenia. The study also aims at examining if an improvement is present three months after completion of the training intervention.

02

Conditions studied

  • Schizophrenia
  • Social Cognition

Browse trials for

Keywords

  • functional capacity
  • training
  • neurocognition
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 48 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • age 18-55
  • diagnosis of schizophrenia or schizoaffective disorder
  • IQ > 69
  • sufficient mastery of Norwegian to undergo assessments

Exclusion criteria

Exclusion Criteria:

  • history of head trauma
  • neurological/medical condition known to interfere with central nervous system
  • receiving outpatient care at time of recruitment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Investigator)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    social cognition training

    Other: Training in Affect Recognition

  • No intervention
    treatment as usual

Interventions

  • OtherTraining in Affect Recognition

    A 12-session social cognitive training programming covering emotion perception and social perception administered in a group setting to up to four participants with schizophrenia at the time

06

What researchers measure

Primary outcomes

  1. Social cognitive tests

    PFA and MASC

    Time frame: Within one week and within three months of completed training

Secondary outcomes

  1. Functional capacity tests

    AIPSS and UPSA-brief

    Time frame: Within one week and within three months of completed training

  2. Neuropsychological tests

    MATRICS

    Time frame: Within one week and within three months of completed training

07

Study locations

1 site
  • Oslo University Hospital
    Oslo, 0424, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01206842
Lead sponsor
Oslo University Hospital
Responsible party
Anja Vaskinn (PhD, Oslo University Hospital) — Principal investigator
First posted
Sep 22, 2010
Start date
Aug 2011
Primary completion
May 1, 2018
Completion
May 1, 2018
Last update
May 22, 2018

Study contacts

Anja Vaskinn, PhD
principal investigator · Oslo University Hospital, Psychosis Research Unit

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion